An open trial of MAO inhibitors in bulimia.
Twelve bulimic women with prominent depression and anxiety were treated with monoamine oxidase inhibitors (MAOIs). A dramatic response was seen in 10 cases. The implications of this open clinical trial for the understanding and treatment of bulimia are discussed.